Comparing quetiapine and trazodone for postpartum depression
Treatments studied
Part of Mental health, Women’s health & pregnancy clinical trials.
This study compares two medications, quetiapine and trazodone, to see which works better for women with postpartum depression. You take one of them for about 8 weeks, and the team checks your mood and side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old.
- You gave birth in the last 6 months.
- You have been diagnosed with major depression that started during pregnancy or after childbirth.
- You are not at high risk of suicide right now.
- You do not have bipolar disorder, schizophrenia, or a psychotic disorder.
- You do not have a medical condition that makes quetiapine unsafe for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a treatment aimed at improving maternal mental health during pregnancy. It focuses on people who have had depression around pregnancy before, and checks whether the approach is safe and helpful for them.
This study checks how people with postpartum depression feel over time after starting zuranolone. It uses simple questionnaires to track changes in symptoms.
This trial tests whether timed light therapy can improve postpartum depression symptoms. It focuses on new mothers within six months of giving birth who have elevated depression scores.
This study looks at using a brain stimulation treatment called TMS (transcranial magnetic stimulation) to help prevent or treat depression after childbirth. It also uses blood and brain wave tests to try to predict who might get postpartum depression, so the right women can get help early.
This trial tests a faster form of TMS (brain stimulation) for people with depression who are pregnant (14-34 weeks) or within one year of giving birth. It aims to see if the treatment is safe and well-tolerated.
This study looks at how the medicine zuranolone (taken for postpartum depression) works in real life for people who got a prescription within a year after their pregnancy ended. Researchers want to see if symptoms improve and how participants feel while taking it.
Hear when a new Postpartum Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.